Clinical trial
Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant…
NCT00170677 · North Eastern German Society of Gynaecological Oncology, Other · Completed
Key facts
| NCT number | NCT00170677 |
|---|---|
| Title | Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer |
| Official title | Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer |
| Lead sponsor | North Eastern German Society of Gynaecological Oncology, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Topotecan |
| Enrollment | 194 |
| Start date | Sep 1, 2005 |
| Primary completion | Jan 1, 2013 |
| Completion | Jan 1, 2013 |
| First posted | Sep 15, 2005 |
| Last update posted | May 14, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: